Topilsky MR - Search Results

1

Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.

Fireman EM, Ben Efraim S, Greif J, Kivity S, Topilsky MR. Fireman EM, et al. Among authors: topilsky mr. Clin Exp Immunol. 1988 Jul;73(1):111-6. Clin Exp Immunol. 1988. PMID: 2971484 Free PMC article.

2

Sarcoidosis: an organized pattern of reaction from immunology to therapy.

Fireman EM, Topilsky MR. Fireman EM, et al. Among authors: topilsky mr. Immunol Today. 1994 May;15(5):199-201. doi: 10.1016/0167-5699(94)90242-9. Immunol Today. 1994. PMID: 7912935

3

Suppressive activity of alveolar macrophages and blood monocytes from interstitial lung diseases: role of released soluble factors.

Fireman E, Ben Efraim S, Greif J, Alguetti A, Ayalon D, Topilsky M. Fireman E, et al. Int J Immunopharmacol. 1989;11(7):751-60. doi: 10.1016/0192-0561(89)90129-x. Int J Immunopharmacol. 1989. PMID: 2557288

4

Release of PGE2 and IL-1 as related to suppressive activity of alveolar macrophages from interstitial lung diseases.

Fireman E, Ben-Efraim S, Topilsky M. Fireman E, et al. Agents Actions. 1989 Jan;26(1-2):173-4. doi: 10.1007/BF02126598. Agents Actions. 1989. PMID: 2785334 No abstract available.

5

Correlation between PGE2 production and suppressor activity of alveolar macrophages from patients with interstitial lung diseases.

Fireman E, Ben Efraim S, Greif J, Alguetti A, Ayalon D, Topilsky M. Fireman E, et al. Immunol Lett. 1988 Jun;18(2):159-65. doi: 10.1016/0165-2478(88)90058-2. Immunol Lett. 1988. PMID: 3165369

6

Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.

Fireman E, Ben-Efraim S, Spinrad S, Topilsky M, Greif J. Fireman E, et al. Eur Respir J. 1993 Jul;6(7):956-64. Eur Respir J. 1993. PMID: 8370444

7

Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases.

Shahar I, Fireman E, Topilsky M, Grief J, Kivity S, Spirer Z, Ben Efraim S. Shahar I, et al. Clin Immunol Immunopathol. 1996 Jun;79(3):244-51. doi: 10.1006/clin.1996.0075. Clin Immunol Immunopathol. 1996. PMID: 8635282

8

Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis.

Fireman E, Vardinon N, Burke M, Spizer S, Levin S, Endler A, Stav D, Topilsky M, Mann A, Schwarz Y, Kivity S, Greif J. Fireman E, et al. Eur Respir J. 1998 Mar;11(3):706-11. Eur Respir J. 1998. PMID: 9596125 Free article.

9

Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases.

Shahar I, Fireman E, Topilsky M, Grief J, Schwarz Y, Kivity S, Ben-Efraim S, Spirer Z. Shahar I, et al. Int J Immunopharmacol. 1999 Nov;21(11):759-75. doi: 10.1016/s0192-0561(99)00056-9. Int J Immunopharmacol. 1999. PMID: 10576621

10

Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease.

Fireman E, Topilsky I, Greif J, Lerman Y, Schwarz Y, Man A, Topilsky M. Fireman E, et al. Respir Med. 1999 Nov;93(11):827-34. doi: 10.1016/s0954-6111(99)90269-x. Respir Med. 1999. PMID: 10603633 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters